IMPROVING LIFE THROUGH BIOSCIENCE
Delivering new discoveries advancing regenerative medicine...
...Through tireless effort and dedication of pioneers in regenerative medicine...
...Expanding applications to human and animal degenerative medical conditions
Our vision is to develop and to provide medical solutions, based upon our advanced new discoveries, to aid both humans and animals around the world who are suffering from various types of degenerative medical conditions.
Through the efforts and dedication of our science team, and those collaborators within the medical community who share our vision and mission, we pursue our vision tirelessly, seeking new means to relieve suffering from degenerative medical conditions.
Non-Immunogenic & Non-tumerogenic
Demonstrated to be non-immunogenic and non-tumerogenic
Recovered From Peripheral Blood
Easily harvested from peripheral or cord blood in acceptable quantities for a a number of applications including banking, therapeutic and tissue enginerring uses
No Expansion Required
No Expansion Required for cell banking or a number of therapeutic applications
A "Blood Component"
Proprietary recovery proceedure falls within the definition of a “blood component” under existing FDA definitions
Tested and proven existence and characterization using all known markers for pluripotency
CURRENT NEWS AND EVENTS
Tithon Biotech, Inc is pleased to announce that Dr. Charles Mahl, has joined Tithon's Scientific and Medical Advisory Board. Comprised of leaders in both research and clinical practice, the Tithon Scientific and Medical Advisory Board provides professional knowledge,...
Tithon Biotech, Inc. is pleased to announce that Mr. Greg King, has joined Tithon Biotech, Inc., as its Chief Executive Officer. Dr. Vasilis (“Bill”) Paspaliaris, Tithon’s founder and Chairman, commented: “On behalf of the board of directors, I would like...
Tithon Biotech, Inc is pleased to announce that Dr. Terry Grossman, a pioneer in the field of nutritional medicine and longevity has joined Tithon's Scientific and Medical Advisory Board. Comprised of leaders in both research and clinical practice, the Tithon...
Thank you to all who attended the First Symposium for the AABRM in Kuala Lumpur 17-18 December 2016, proudly sponsored by Tithon Biotech, Inc. Please see the below video which summarizes the event.